RUNX1 silencing protects against cerebral ischemia/reperfusion injury-induced endoplasmic reticulum stress, inflammation, ferritinophagy and ferroptosis through the CELF2/mTOR axis.
Aug 2026· Toxicology and Applied Pharmacology· Vol 515, pp.
117990
· 0 citations· 41 references
Medicine
Abstract
Ischemic stroke is a prevalent cerebrovascular disease and remains a major cause of chronic disability and death worldwide. Runt-related transcription factor-1 (RUNX1) is a critical member of the core-binding factor family abnormally elevated in ischemic brain tissue. However, the exact roles of RUNX1 and its underlying cellular mechanisms in cerebral ischemia/reperfusion (I/R) injury have not been explored. Here we found that RUNX1 was highly expressed in brain tissues from middle cerebral artery occlusion (MCAO) mice and oxygen-glucose deprivation and reperfusion (OGD/R)-treated HT22 cells. In vivo experiments also showed that knockdown of RUNX1 significantly reduced the infarct volume and ameliorated neurological deficits in MCAO mice. Next, we investigated the exact mechanisms underlying the neuroprotective effect of si-RUNX1 against cerebral I/R injury. The results showed that knockdown of RUNX1 suppressed endoplasmic reticulum stress (ERS) and ERS-mediated neuroinflammation, as well as ferritinophagy and ferroptosis in both MCAO mice and OGD/R-treated HT22 cells. Mechanistically, RUNX1 directly targeted ELAV-like family protein 2 (CELF2) and regulated its transcription, therefore regulating the mTOR signaling. We also found that CELF2/mTOR mediated the inhibitory effects of si-RUNX1 on ERS-mediated inflammation and ferritinophagy-mediated ferroptosis both in vivo and in vitro. In summary, these data taken together revealed that si-RUNX1 suppressed ERS-mediated neuroinflammation and ferritinophagy-mediated ferroptosis through regulating the CELF2/mTOR signaling. These findings indicated that RUNX1/CELF2/mTOR might serve as therapeutic targets for cerebral I/R injury.
Ferroptosis has a crucial role in cerebral ischemia-reperfusion injury (IRI) but its potential modulation is a key challenge in the treatment of ischemic stroke. The function and mechanism of the E3 ubiquitin ligase tripartite motif-containing protein 21 (TRIM21) in neurological diseases, particularly its regulatory role in ferroptosis are unclear. We used a mouse model of transient middle cerebral artery occlusion (tMCAO/R) and a PC12 cell model of oxygen-glucose deprivation/reperfusion (OGD/R) to investigate the effects of virus-mediated gene knockdown of TRIM21. Effects were assessed using Western blotting, immunoprecipitation, biochemical assays, and behavioral tests. TRIM21 expression was significantly increased after cerebral IRI. Knockdown of TRIM21 improved neurological deficits, reduced cerebral infarct size, and suppressed inflammation. Knockdown of TRIM21 also inhibited ferroptosis and improved mitochondrial function whereas TRIM21 negatively regulated the p62-Keap1-Nrf2 pathway through ubiquitination of p62. Salvage experiments confirmed that Nrf2 is a key downstream molecule for the neuroprotective effects of TRIM21. The data indicate that TRIM21 inhibition of the Keap1-Nrf2 pathway through p62 ubiquitination exacerbated ferroptosis after ischemic stroke in the tMCAO/R model and suggest that targeted inhibition of TRIM21 holds promise as a novel strategy for treating ischemic stroke.
Bo Yang, Yanxia Sun, Yao Zhang et al.· Journal of Neuropathology an...· 0 citations
Abstract Cerebral ischemia-reperfusion injury (CIRI) involves complex pathological mechanisms, including ferroptosis. Curcumin exhibits neuroprotective properties, but its role in modulating ferroptosis during CIRI remains incompletely understood. This research explored how curcumin protects against ferroptosis in CIRI and the molecular mechanisms involved. In vivo, male MCAO rats were divided into Sham, MCAO, and curcumin low/medium/high-dose groups. Infarct volume, neurological deficit scores, and ferroptosis markers (MDA, Fe2+, GSH, GPX4, FTH1, TfR1) were detected. In vitro, OGD/R-stimulated BV2 cells were administered with curcumin or Ferrostatin-1. GPX4 knockdown, KLF2, and KAT2A overexpression or knockdown were performed. ChIP, CCK-8, and western blotting were applied to identify H3K18ac modification, cell viability, and protein expression, respectively. In MCAO rats, curcumin administration led to a reduction in infarct size, better neurological outcomes, and a decrease in ferroptosis. In vitro, curcumin inhibited OGD/R-stimulated ferroptosis and enhanced H3K18 acetylation at the GPX4 promoter. Mechanistically, curcumin upregulated the transcription factor KLF2, which transcriptionally activated the histone acetyltransferase KAT2A. KAT2A mediated H3K18ac modification at the GPX4 promoter, leading to GPX4 upregulation and ferroptosis suppression. KLF2 knockdown abolished the protective effects of curcumin. In conclusion, Curcumin inhibited ferroptosis in CIRI by activating the KLF2/KAT2A/GPX4 signaling axis, highlighting a novel epigenetic mechanism and potential therapeutic strategy for ischemic stroke. HIGHLIGHTS Curcumin prevented ferroptosis in MCAO rats Curcumin enhanced GPX4 H3K18ac modification and inhibited ferroptosis KAT2A mediated GPX4 H3K18ac modification and suppressed BV2 cells ferroptosis under OGD/R conditions KLF2 transcriptionally activated KAT2A and inhibited OGD/R-stimulated BV2 cells ferroptosis By activating the KLF2/KAT2A/GPX4 axis, curcumin prevented ferroptosis in BV2 cells subjected to OGD/R.
BACKGROUND
Cerebral ischemia/reperfusion injury remains a major barrier to neurological recovery after recanalization therapy. Although remote ischemic postconditioning (RIPostC) has neuroprotective potential, its non-coding RNA mechanisms remain unclear. This study investigated whether the circular RNA 0004468 (circRNA_0004468)/microRNA-1224 (miR-1224)/vascular endothelial growth factor A (VEGFA) axis mediates RIPostC-induced protection against cerebral ischemia/reperfusion injury.
METHODS
Oxygen-glucose deprivation/reoxygenation (OGD/R)-treated PC12 cells were used as an in vitro model of ischemia-reperfusion injury, whereas rats subjected to ischemia/reperfusion (I/R), with or without RIPostC, were used for in vivo validation. The expression of circRNA_0004468, miR-1224, VEGFA, and PI3K-related proteins was examined by reverse-transcription quantitative polymerase chain reaction (RT-qPCR) and Western blotting. Cell viability, apoptosis, molecular interactions, infarct volume, histopathological injury, neurological deficits, and endothelial repair were evaluated using Cell Counting Kit-8 (CCK-8) assay, flow cytometry, fluorescence in situ hybridization, dual-luciferase reporter assay, 2,3,5-triphenyltetrazolium chloride (TTC) staining, hematoxylin-eosin staining, behavioral scoring, and immunofluorescence staining.
RESULTS
OGD/R decreased circRNA_0004468 and VEGFA expression but increased miR-1224 expression in PC12 cells. CircRNA_0004468 overexpression or miR-1224 inhibition improved cell viability and reduced apoptosis after OGD/R. Mechanistically, circRNA_0004468 directly bound to miR-1224 and relieved miR-1224-mediated suppression of VEGFA. In MCAO/R rats, RIPostC upregulated circRNA_0004468 and VEGFA, downregulated miR-1224, reduced infarct volume, alleviated neuronal injury, enhanced CD31 and CD34 expression, and improved neurological outcomes. These protective effects were further strengthened by circRNA_0004468 overexpression, miR-1224 inhibition, or VEGFA overexpression.
CONCLUSIONS
The circRNA_0004468/miR-1224/VEGFA axis contributes to RIPostC-mediated neurovascular protection and may represent a potential target for improving recovery after ischemic stroke.
Chunyan Li, Chuang Liu, Yu-Xian Liu et al.· Brain Research Bulletin· 0 citations